WEKO3
アイテム
{"_buckets": {"deposit": "8ceceb9c-a04f-4227-83bc-c9468012fa82"}, "_deposit": {"created_by": 1, "id": "56107", "owners": [1], "pid": {"revision_id": 0, "type": "depid", "value": "56107"}, "status": "published"}, "_oai": {"id": "oai:repo.qst.go.jp:00056107", "sets": ["7"]}, "author_link": ["574027", "574029", "574030", "574031", "574032", "574028", "574026"], "item_10004_biblio_info_7": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2018-03", "bibliographicIssueDateType": "Issued"}, "bibliographicPageEnd": "86", "bibliographicPageStart": "86", "bibliographic_titles": [{"bibliographic_title": "QST Takasaki Annual Report 2016"}]}]}, "item_10004_description_5": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "We demonstrate that the use of histone deacetylase inhibitors (HDACi) could sensitize refractory tumor cells well for the heavy-ion therapy. B16F10 murine melanoma cells were treated with several HDACis and followed by irradiations. Thereafter, immunofluorescence microscopy ofγH2AX were carried out. Foci size of γH2AX in γ-ray irradiated cells became bigger by pretreatment with HDACis, although foci size of γH2AX in heavy-ion irradiated cells was almost unchanged by pretreatment with HDACis.", "subitem_description_type": "Abstract"}]}, "item_10004_publisher_8": {"attribute_name": "出版者", "attribute_value_mlt": [{"subitem_publisher": "Takasaki Advanced Radiation Research Institute, QST"}]}, "item_access_right": {"attribute_name": "アクセス権", "attribute_value_mlt": [{"subitem_access_right": "metadata only access", "subitem_access_right_uri": "http://purl.org/coar/access_right/c_14cb"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "斎藤, 克代 (高崎健康福祉大)"}], "nameIdentifiers": [{"nameIdentifier": "574026", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "舟山, 知夫"}], "nameIdentifiers": [{"nameIdentifier": "574027", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "横田, 裕一郎"}], "nameIdentifiers": [{"nameIdentifier": "574028", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "小林, 泰彦"}], "nameIdentifiers": [{"nameIdentifier": "574029", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "舟山 知夫", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "574030", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "横田 裕一郎", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "574031", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "小林 泰彦", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "574032", "nameIdentifierScheme": "WEKO"}]}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "article", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "Epigenetic Modifier as a Potential Radiosensitizer for Heavy-ion Therapy on Malignancy (V)", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "Epigenetic Modifier as a Potential Radiosensitizer for Heavy-ion Therapy on Malignancy (V)"}]}, "item_type_id": "10004", "owner": "1", "path": ["7"], "permalink_uri": "https://repo.qst.go.jp/records/56107", "pubdate": {"attribute_name": "公開日", "attribute_value": "2018-04-26"}, "publish_date": "2018-04-26", "publish_status": "0", "recid": "56107", "relation": {}, "relation_version_is_last": true, "title": ["Epigenetic Modifier as a Potential Radiosensitizer for Heavy-ion Therapy on Malignancy (V)"], "weko_shared_id": -1}
Epigenetic Modifier as a Potential Radiosensitizer for Heavy-ion Therapy on Malignancy (V)
https://repo.qst.go.jp/records/56107
https://repo.qst.go.jp/records/56107dcb97cc6-34ba-421d-8fc1-ca8d52aeb826
Item type | 一般雑誌記事 / Article(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2018-04-26 | |||||
タイトル | ||||||
タイトル | Epigenetic Modifier as a Potential Radiosensitizer for Heavy-ion Therapy on Malignancy (V) | |||||
言語 | ||||||
言語 | eng | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
資源タイプ | article | |||||
アクセス権 | ||||||
アクセス権 | metadata only access | |||||
アクセス権URI | http://purl.org/coar/access_right/c_14cb | |||||
著者 |
斎藤, 克代 (高崎健康福祉大)
× 斎藤, 克代 (高崎健康福祉大)× 舟山, 知夫× 横田, 裕一郎× 小林, 泰彦× 舟山 知夫× 横田 裕一郎× 小林 泰彦 |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | We demonstrate that the use of histone deacetylase inhibitors (HDACi) could sensitize refractory tumor cells well for the heavy-ion therapy. B16F10 murine melanoma cells were treated with several HDACis and followed by irradiations. Thereafter, immunofluorescence microscopy ofγH2AX were carried out. Foci size of γH2AX in γ-ray irradiated cells became bigger by pretreatment with HDACis, although foci size of γH2AX in heavy-ion irradiated cells was almost unchanged by pretreatment with HDACis. | |||||
書誌情報 |
QST Takasaki Annual Report 2016 p. 86-86, 発行日 2018-03 |
|||||
出版者 | ||||||
出版者 | Takasaki Advanced Radiation Research Institute, QST |